An Optimised GA Interventional Trial (Opti-GAIN) to Test if Treatment With CTx001 is Safe and Works for People With Geographic Atrophy (GA)
An Optimised GA Interventional Trial (Opti-GAIN) to Test if Treatment With CTx001 is Safe and Works for People With Geographic Atrophy (GA)
Recruiting · NCT07392255 · Registry updated 2026-10-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| An Optimised GA Interventional Trial (Opti-GAIN) to Test if Treatment With CTx001 is Safe and Works for People With Geographic Atrophy (GA) | Geographic Atrophy Secondary to Age-related Macular Degeneration | Recruiting | Phase 1 / Phase 2 | 2026-10-08 | NCT07392255 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Complement Therapeutics | 3 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Gloucestershire Royal Hospital | Gloucester | United Kingdom | 5 |
| Gundersen Health System | La Crosse | United States | 11 |
| Midwest Eye Institute | Carmel | United States | 5 |
| Retina Foundation of the Southwest | Dallas | United States | 38 |
| Sierra Eye Associates | Reno | United States | 30 |
| Sunderland Specialist Eye Hospital | Sunderland | United Kingdom | 1 |
| The Retina Clinic London | London | United Kingdom | 1 |